Amgen Inc vs. C4 Therapeutics, Inc.
Amgen Inc (AMGN) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| AMGN | CCCC | |
|---|---|---|
| Market Cap | $219.02 billion | $402.46 million |
| Revenue (TTM) | $38.09 billion | $34.86 million |
| Net Income (TTM) | $8.74 billion | $-103,801,000 |
AMGN leads on 3 of 3 size & scale factors.
Valuation
| AMGN | CCCC | |
|---|---|---|
| P/E Ratio | 25.15 | — |
| Price / Book | 18.74 | 1.72 |
| Price / Sales | 5.75 | 11.54 |
AMGN and CCCC split the valuation factors evenly.
Profitability
| AMGN | CCCC | |
|---|---|---|
| Net Margin | 22.95% | -297.76% |
| Return on Equity | 74.80% | -44.31% |
AMGN leads on 2 of 2 profitability factors.
Dividend
| AMGN | CCCC | |
|---|---|---|
| Dividend Yield | 2.49% | — |
| Payout Ratio | 62.61 | — |
AMGN and CCCC split the dividend factors evenly.
Risk & Sentiment
| AMGN | CCCC | |
|---|---|---|
| Short Interest | 1.67% | 0.32% |
CCCC leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, CCCC overview, CCCC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.